Literature DB >> 25510679

The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression.

Kay-Dietrich Wagner1, Julien Cherfils-Vicini1, Naoki Hosen2, Peter Hohenstein3, Eric Gilson4, Nicholas D Hastie5, Jean-François Michiels6, Nicole Wagner1.   

Abstract

Angiogenesis, activation of metastasis and avoidance of immune destruction are important for cancer progression. These biological capabilities are, apart from cancer cells, mediated by different cell types, including endothelial, haematopoietic progenitor and myeloid-derived suppressor cells. We show here that all these cell types frequently express the Wilms' tumour suppressor Wt1, which transcriptionally controls expression of Pecam-1 (CD31) and c-kit (CD117). Inducible conditional knockout of Wt1 in endothelial, haematopoietic and myeloid-derived suppressor cells is sufficient to cause regression of tumour vascularization and an enhanced immune response, leading to decreased metastasis, regression of established tumours and enhanced survival. Thus, Wt1 is an important regulator of cancer growth via modulation of tumour vascularization, immune response and metastasis formation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25510679     DOI: 10.1038/ncomms6852

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  39 in total

Review 1.  Emerging Complexities in Adipocyte Origins and Identity.

Authors:  Joan Sanchez-Gurmaches; Chien-Min Hung; David A Guertin
Journal:  Trends Cell Biol       Date:  2016-02-11       Impact factor: 20.808

2.  G-quadruplex forming region within WT1 promoter is selectively targeted by daunorubicin and mitoxantrone: A possible mechanism for anti-leukemic effect of drugs.

Authors:  Saeedeh Ghazaey Zidanloo; Abasalt Hosseinzadeh Colagar; Hossein Ayatollahi; Zahra Bagheryan
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

3.  HIF-2α, acting via miR-191, is involved in angiogenesis and metastasis of arsenite-transformed HBE cells.

Authors:  Wenchao Xu; Fei Luo; Baofei Sun; Hua Ye; Jun Li; Le Shi; Yi Liu; Xiaolin Lu; Bairu Wang; Qingling Wang; Qizhan Liu; Aihua Zhang
Journal:  Toxicol Res (Camb)       Date:  2015-11-06       Impact factor: 3.524

4.  Hippo Signaling Mediators Yap and Taz Are Required in the Epicardium for Coronary Vasculature Development.

Authors:  Anamika Singh; Sindhu Ramesh; Dasan Mary Cibi; Lim Sze Yun; Jun Li; Li Li; Lauren J Manderfield; Eric N Olson; Jonathan A Epstein; Manvendra K Singh
Journal:  Cell Rep       Date:  2016-05-05       Impact factor: 9.423

5.  Fetal kidney stem cells ameliorate cisplatin induced acute renal failure and promote renal angiogenesis.

Authors:  Ashwani Kumar Gupta; Sachin H Jadhav; Naresh Kumar Tripathy; Soniya Nityanand
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

Review 6.  Promising new treatments for pancreatic cancer in the era of targeted and immune therapies.

Authors:  Ahmed Elaileh; Ashish Saharia; Lucy Potter; Flavio Baio; Afnan Ghafel; Maen Abdelrahim; Kirk Heyne
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

7.  Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2.

Authors:  Julien Cherfils-Vicini; Charlene Iltis; Ludovic Cervera; Sabrina Pisano; Olivier Croce; Nori Sadouni; Balázs Győrffy; Romy Collet; Valérie M Renault; Martin Rey-Millet; Carlo Leonetti; Pasquale Zizza; Fabrice Allain; Francois Ghiringhelli; Nicolas Soubeiran; Marina Shkreli; Eric Vivier; Annamaria Biroccio; Eric Gilson
Journal:  EMBO J       Date:  2019-04-18       Impact factor: 11.598

8.  Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse.

Authors:  Delphine Baudouy; Jean-François Michiels; Ana Vukolic; Kay-Dietrich Wagner; Nicole Wagner
Journal:  J Vis Exp       Date:  2017-10-26       Impact factor: 1.355

9.  Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma.

Authors:  Tomoya Kanai; Zensho Ito; Yusuke Oji; Machi Suka; Sumiyuki Nishida; Kazuki Takakura; Mikio Kajihara; Masayuki Saruta; Shuichi Fujioka; Takeyuki Misawa; Tadashi Akiba; Hiroyuki Yanagisawa; Shigetaka Shimodaira; Masato Okamoto; Haruo Sugiyama; Shigeo Koido
Journal:  Oncol Lett       Date:  2018-06-13       Impact factor: 2.967

10.  Wilms' tumor in a 51-year-old patient: An extremely rare case and review of the literature.

Authors:  Jia Hu; L U Jin; Tao He; Yifan Li; Yang Zhao; Y U Ding; Xianxin Li; Yunchu Liu; Yaoting Gui; Xiangming Mao; Yongqing Lai; Liangchao Ni
Journal:  Mol Clin Oncol       Date:  2016-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.